PERTH, Australia, Jan. 12, 2026 /PRNewswire/ -- Artemis SailGP is pleased to announce Sandmark as an Official Partner, ahead of the team's debut in the Rolex SailGP Championship in Perth, Australia this weekend (17–18 January).
Sandmark has joined Artemis SailGP as an Official Partner, supporting the Swedish team as it competes in SailGP's high-tech 50-foot foiling catamarans at iconic venues worldwide. As an Official Partner, Sandmark supports Artemis SailGP in its pursuit of innovation, speed, and performance at the forefront of racing.
Built for an audience that values clarity, credibility, and depth, the Sandmark platform takes a new and serious approach to global crypto market news and analysis. Sandmark delivers high-quality journalism and informed perspectives in a fast-evolving digital and financial landscape.
Both brands share a dedication to precision and innovation. While Artemis SailGP leverages data, engineering, and analytics to maximize performance on the water, Sandmark applies the same technology-led rigour to providing clear, credible insights in the fast-moving world of global crypto markets.
Commenting on the partnership, Iain Percy, CEO of Artemis SailGP, said:
"We are pleased to welcome Sandmark as an Official Partner. Their commitment to credible, high-quality analysis complements our pursuit of performance and precision on the water. Partnerships like this help us connect with audiences who share our passion for innovation and excellence, and we look forward to showcasing this collaboration as we prepare to compete in the championship."
Giles Broom, Editor-in-Chief at Sandmark, added:
"We're thrilled to support Artemis SailGP for the 2026 season and we take great inspiration from a world-class team competing in one of the fastest-growing sports globally. That mirrors Sandmark's own trajectory as we enter the crypto media space, drawing on deep experience and knowledge to bring rigour and clarity to this evolving asset class. We're honoured to join Artemis SailGP on this journey, where speed, technology, and teamwork converge in pursuit of excellence."
Artemis SailGP will make their highly anticipated SailGP debut this weekend (17–18 January) in the Oracle Perth Sail Grand Prix presented by KPMG. Helmed by Driver Nathan Outteridge and joined by Andy Maloney, Chris Draper, Julia Gross, Brad Farrand, and Julius Hallström, the team is marking Sweden's entry into the league.
Follow Artemis SailGP:
ABOUT ARTEMIS SAILGP | Artemis SailGP marks the first time Sweden is participating in the SailGP championship. Building on the world-class legacy of Artemis Racing, from RC44 victories to America's Cup campaigns, Artemis SailGP continues that tradition of excellence, innovation, and ambition. Now, Sweden enters the SailGP championship with a new era of speed, skill, and global competition.
ABOUT SANDMARK | Sandmark is an independent, family-owned media platform with a new and serious approach to global crypto market news and analysis. Sandmark enables crypto investors and enthusiasts to understand the evolving world of crypto markets through regular and actionable insights: we seek to define this increasingly mainstream asset class with clear reporting and analysis. Meanwhile, Sandmark's Research and Technology teams work hard to address the reliability gap in digital asset markets through an innovative approach to data and tools.
ABOUT SAILGP | The most exciting racing on water, the Rolex SailGP Championship sees national teams battling it out in identical high-tech, high-speed 50-foot foiling catamarans at iconic venues around the world. Racing faster than the wind at speeds in excess of 100 km/h (60 mph), SailGP is driven by the sport's top athletes, with national pride, personal glory, and total prize money of US$12 million at stake. Powered by nature - wind, sea, and sun - driven by purpose, SailGP races for a better future. Visit SailGP.com to find out more.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Crypto News and Data Platform Sandmark Joins Artemis SailGP as Official Partner Ahead of 2026 Season
SINGAPORE, Sept. 18, 2026 /PRNewswire/ -- A report from Ringiertrade.
The recently concluded Medical Fair Asia 2026, Southeast Asia's Leading International Healthcare Trade Fair for the medical and healthcare sectors, provided opportunities for leading companies to unveil their products and services for this dynamic regional market. Held from 9-11 September in Singapore, Medical Fair Asia featured equipment and supplies for the pharmaceutical, medical and rehabilitation sectors and brought together healthcare professionals, medical device manufacturers, suppliers and industry leaders from around the world.
ROSTI Group, represented by Rosti Asia Integrated Solutions Pte Ltd, demonstrated its extensive experience in medical device and healthcare product manufacturing at the exhibition. Highlighted at the exhibition was ROSTI's capabilities ranging from precision injection moulding, cleanroom manufacturing, product assembly and integrated manufacturing solutions.
At the ROSTI booth, Melvin Tan, Vice President-Sales Asia, discussed how ROSTI has been supporting customers in the region in developing and producing healthcare products that meet the most stringent standards in this industry.
Innovations for Southeast Asia's fast-growing medical sector
As a highly dynamic region, Southeast Asia is experiencing significant growth in medical and pharmaceutical products manufacturing, driven by rising consumer purchasing power, advances in production technologies and favourable government incentives.
ROSTI's medical solutions presented at the Medical Fair Asia are based on four pillars: customer centricity, global footprint, operational excellence, and willingness to invest. As Melvin Tan puts it: "As far as customer centricity is concerned, we focus primarily on ensuring that we participate actively in our customer's product development – from concept to reality. For medical product design, ROSTI provides case design, prototyping, 3D printing and also some of the samples that we can turn around within 72 hours." He also stressed how ROSTI supports its customers in process technology since the medical industry has stringent process control and standards. ROSTI's strong capabilities in plastic injection moulding and the application of sustainable materials are advantages that would benefit customers in their medical manufacturing requirements, according to Melvin.
Countries in the region are adopting more stringent standards for medical and pharmaceutical products that compliance must be part of the game plan of manufacturers. As Melvin explained, ROSTI has an ISO Class 8 cleanrooms to make sure that ROSTI is able to manufacture the products designed or built for its customers. "In every innovation that we bring to our customer's device, the whole process has been well documented – starting from the design, material control, traceability and actual production. It is very important to make sure that when we design and launch a product for our customers, our sites understand what is expected out of this product and then we are ready to go. These are all part of ROSTI's innovations."
Navigating today's demand markets for medical devices
Today's medical device requirements are evolving with faster turnaround time being demanded from manufacturers. In this aspect, ROSTI has successfully navigated market changes through its research and development strategy that enables it to evolve quickly and abide by the regulations. "Because regulation is getting tighter, we need to strike a balance on market changes plus regulation. As I mentioned, the concept to reality is not just a slogan but making sure that we are able to control everything in-house – from the design to tooling and moulding up to the rest of the process. This helps us navigate in this market because we understand the customer's requirement while making sure that we are in compliance with the regulations."
ROSTI employs a technical team composed of experienced professionals in polymer engineering. Hence, different types of materials are studied, while sustainability is also taken as a critical aspect. Also, given the material of choice, the ROSTI team ensures that it will be able to work with tooling, mold and all other aspects of production to meet the customer's requirement.
Across Asia, ROSTI has been offering a full concept of value chain, according to Melvin. This covers not only designing the product and production process but the whole value chain where ROSTI works in partnership with the customer and understands the whole supply chain management required to successfully produce the medical device.
"Supply chain resilience is very important right now - world-class manufacturing and logistics – and ROSTI is trying to manage not just concept of value, but the whole product lifecycle management, making sure that products are delivered on time," according to Melvin.
Currently, ROSTI operates customer care centres in all its Asian sites – China, Malaysia, India and Singapore – providing customers with faster and more efficient response. "ROSTI has its presence in different sites in Asia and one of them is in Suzhou, China where ROSTI has its largest site in Asia. This site has evolved to become an important medical manufacturing hub housing ROSTI's innovation centre, and it actually performs full contract manufacturing. Our Malaysia and India site achieved high level of manufacturing expertise to work with customers in this region," Melvin added.
When asked about the sustainability target, Melvin explained that sustainability has been built into ROSTI's design and manufacturing process. The company has been able to reduce its greenhouse gas emissions by 44% since 2023 with the goal of making significant progress toward cutting those emissions by half in 2030.
For ROSTI, market challenges are opportunities to further enhance its innovative spirit. In Southeast Asia and globally, customers confidence can be achieved through a strong partnership founded on providing reliable, highly efficient design and manufacturing services aligned with the dynamic medical and pharmaceutical industry.
About Rosti Group
Founded in 1944 with headquarters in Malmö, Sweden, the Group has 2,700 existing employees across thirteen facilities in the United States, Europe, and Asia. A global plastics injection moulding company and contract manufacturer to some of the world's leading manufacturers in the packaging, consumer appliances, business machines, and medical sectors, Rosti is dedicated to providing leading-edge solutions "From concept to reality" to help customers create better components, processes and solutions. Rosti is owned by the family-controlled investment company Nordstjernan. Please visit: http://www.rosti.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Rosti Group highlights cutting-edge medical solutions at Medical Fair Asia 2026
